Riskpilot← Back to searchSign inGet full accessTermino C 14914 AB
ABDissolvedOrg 5567705735Medical specialists activities · NACE 8622Est. 20080 employees
Revenue 2024
SEK 2,4M
+3% vs 2023
EBITDA margin
13.9%
+35% vs 2023
Equity ratio
75.4%
Financial strength
Net profit 2024
SEK 323K
+65% vs 2023
| Revenue | SEK 2,4M | +3% |
| EBITDA | SEK 339K | +35% |
| Net profit | SEK 323K | +65% |
| Total assets | SEK 935K | +28% |
| Equity | SEK 704K | +63% |
| Employees | 0 | — |
Legal name
Termino C 14914 AB
Org number
5567705735
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 november 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 367 | 2 427 | 2 347 | 2 356 | 2 432 |
| Staff expenses | — | — | −2 085 | −1 906 | −1 882 |
| EBITDA | 111 | 20 | 79 | 251 | 339 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 111 | 20 | 79 | 251 | 339 |
| Net financials | — | — | −0 | 4 | 6 |
| Profit before tax | 79 | 20 | 78 | 255 | 420 |
| Tax | −21 | −8 | −22 | −59 | −97 |
| Net profit | 58 | 12 | 56 | 196 | 323 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 575 | 658 | 585 | 730 | 935 |
| Equity | 317 | 279 | 285 | 431 | 704 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 183 | 304 | 224 | 224 | 230 |
| Total debt | 183 | 304 | 224 | 224 | 230 |
EBITDA margin
13.9%
This company
15.8%
Market median
-12% vs market
20202024
Equity ratio
75.4%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
45.9%
This company
18.4%
Market median
+149% vs market
20202024
Net profit margin
13.3%
This company
8.1%
Market median
+64% vs market
20202024
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LE Chief Executive Officer | Chief Executive Officer | 2022 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2025 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 14914 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Eric Sundquist | Chief Executive Officer | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Iréne Virginia Stark | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Nathalie Madelene Stark Sundquist | Deputy Board Member | 0 companies |